Colgate-Palmolive (NYSE: CL) reported Q4 EPS of $0.87, $0.02 better than the analyst estimate of $0.85. Revenue for the quarter came in at $4.95 billion versus the consensus estimate of $4.89 billion.

GUIDANCE:

Based on current spot rates:

The Company expects net sales growth to be 1% to 4% including a low-single-digit negative impact from foreign exchange.
The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%.
On a GAAP basis, the Company expects gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth.
On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion, increased advertising investment and mid to high-single-digit earnings-per-share growth.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.